Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 133Precursor Cell Lymphoblastic Leukemia-Lymphoma 118Myelodysplastic Syndromes 105Lymphoma, Non-Hodgkin 85Leukemia, Lymphocytic, Chronic, B-Cell 85Leukemia 81Hodgkin Disease 80Multiple Myeloma 70Lymphoma, Mantle-Cell 60Leukemia, Myelogenous, Chronic, BCR-ABL Positive 59Lymphoma, Follicular 57Lymphoma 56Myeloproliferative Disorders 55Lymphoma, B-Cell, Marginal Zone 53Leukemia, Myelomonocytic, Chronic 50Burkitt Lymphoma 48Lymphoma, Large B-Cell, Diffuse 46Hematologic Neoplasms 42Congenital Abnormalities 42Lymphoma, Large-Cell, Immunoblastic 35Leukemia, Myeloid, Accelerated Phase 35Leukemia, Myeloid, Chronic-Phase 34Anemia, Refractory, with Excess of Blasts 34Waldenstrom Macroglobulinemia 33Primary Myelofibrosis 32Leukemia, Biphenotypic, Acute 32Blast Crisis 28Lymphoma, Large-Cell, Anaplastic 27Lymphoma, T-Cell, Cutaneous 26Dendritic Cell Sarcoma, Interdigitating 26

Interventions

fludarabine 3filanesib 2Tacrolimus 2Steroids 2Injections, Subcutaneous 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Dexamethasone 2Bortezomib 2Alemtuzumab 2ofatumumab 1fludarabine phosphate 1Zoledronic Acid 1Whole-Body Irradiation 1Stem Cell Transplantation 1Proteasome Inhibitors 1Mycophenolic Acid 1Lenalidomide 1KW-2478 1Hsp90 inhibitor KU757 1Denosumab 1Cyclophosphamide 1Clonal Hematopoiesis 1Chromatin Immunoprecipitation Sequencing 1CLR1404 1Busulfan 1Blood Cell Count 1ARQ531 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Paraproteinemias × Whole-Body Irradiation × Other hematologic neoplasm × Clear all
NCT02556931 2022-11-03

Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
117 enrolled 27 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Paraproteinemias, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myelomonocytic, Chronic, Neoplasms, Plasma Cell, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡